DD · NYSE · STOCK
DuPont (DD) Stock Analysis
$129.97
52W $93.66 – $157.98
60/100
$17.55B
282.6
1.08
Is DD Bullish or Bearish?
Bullish.
Innellis AI committee rates DuPont (DD) Buy with a composite score of 60/100
, based on 6 analysts with 67% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +14.57 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -5.43 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.23) -- balance sheet can absorb a shock. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Price-to-book of 1.2x is a discount to asset value — Value
- 3 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.23) -- balance sheet can absorb a shock — Risk
Bear Case
- P/E of 320.4 is expensive by classic value standards — Value
- ROE of only 0.3% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Price structure making lower highs and lower lows — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
60/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 26%
of 99 Basic Materials peers
Value Analyst
neutral
50
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ Price-to-book of 1.2x is a discount to asset value
− P/E of 320.4 is expensive by classic value standards
Growth Analyst
neutral
52
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 3 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
56
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.23) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 60.4 to 60.4.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
45.5
Neutral
MACD Histogram
0.460
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Support
$126.14
Resistance
$149.34
Bollinger %B
0.50
Inside Bands
Price vs Moving Averages
EMA 9
$130.90
Below
EMA 21
$131.05
Below
EMA 50
$133.29
Below
EMA 200
$144.74
Below
Fundamental Analysis
Valuation
67
Growth
55
Profitability
10
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
282.6×
P/B Ratio
1.29×
PEG Ratio
-0.15
Dividend Yield
1.85%
52W High
$157.98
52W Low
$93.66
Quality & Growth
ROE
-559.7%
ROA
-361.1%
Gross Margin
3438.6%
Operating Margin
1471.3%
Revenue Growth YoY
—
Debt / Equity
0.23
AI Fundamental Assessment
P/E ratio of 282.6 (rich relative to a 15-40x range); Price-to-book of 1.3x; PEG ratio of -0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -5.6%; Return on assets of -3.6%; Net margin of 0.7%; Gross margin of 34.4%; Current ratio of 2.43 (healthy short-term liquidity); Debt-to-equity of 0.23; Free cash flow per share is positive (8.28); Most recent quarter beat estimates by 3.7%; 3 consecutive earnings beats; EPS growth decelerating (+19.6% -> +13.9% QoQ); Average YoY EPS growth of -44.0%; Analyst estimates rising over recent quarters
Get the Full DD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →